Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that the U.S. Food and Drug Administration (FDA) has accepted and granted priority review to a supplemental ...

In the latest restructuring, Genentech will lose 29-year veteran Vishva Dixit, the vice president of its physiological chemistry unit; Todd McDevitt, head of cell therapy, and Man-Wah Tan, a vice ...

A newly unsealed whistleblower lawsuit accuses Novartis and Genentech of being at the center of a decades-long kickback ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today that it will present more than 30 abstracts across more than 10 ...

Genentech is working with Congress and the Centers for Medicare and Medicaid Services (CMS) to offer suggestions for changes to IRA. But the company is considering legal action as well, CEO Alexander ...

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today positive results from the Phase III INAVO120 study of the ...

Elaine’s stories explore the boom in new obesity treatments, new drug payment models, the ways companies are affected by FDA changes, and the emerging psychedelics drug sector. She co-writes The ...

SOUTH SAN FRANCISCO, Calif., June 01, 2026--(BUSINESS WIRE)--Genentech, a member of the Roche Group (SIX: RO, ROP; OTCQX: RHHBY), announced today that new data from its obesity portfolio will be ...

Industry Veteran Brings More Than Three Decades of Biopharmaceutical Development and Clinical Operations Experience to Help Guide Pipeline Advancement ...

We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you ...